Also, interventions aimed at treating GvHD itself appear to impact on thymic recovery and the naïve T cell pool, where an association between systemic steroid treatment and delayed CD4+ T-cell recovery has been noted (74). The gene discussed is CD4; the disease is graft versus host disease.